XWELL (XWEL) 10-Q 9 Aug 17 2017 Q2 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	6 Months Ended
	Jun. 30, 2017	Aug. 07, 2017
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2017
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q2
Entity Registrant Name	FORM Holdings Corp.
Entity Central Index Key	1,410,428
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Trading Symbol	FH
Entity Common Stock, Shares Outstanding		26,483,467

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2017	Dec. 31, 2016
Current assets
Cash and cash equivalents	$ 7,958	$ 17,910
Accounts receivable, net	2,216	404
Inventory	4,327	2,890
Other current assets	935	2,150
Assets held for disposal	467	1,507
Total current assets	15,903	24,861
Restricted cash	476	638
Property and equipment, net	14,377	16,284
Intangible assets, net	14,475	15,233
Goodwill	25,821	24,409
Other assets	1,330	1,382
Total assets	72,382	82,807
Current liabilities
Accounts payable, accrued expenses and other current liabilities	11,437	11,434
Deferred revenue	201	133
Liabilities held for disposal	97	206
Total current liabilities	11,735	11,773
Long-term liabilities
Debt	6,500	6,500
Derivative warrant liabilities	100	259
Other liabilities	794	106
Total liabilities	19,129	18,638
Commitments and contingencies (see Note 11)
Equity
Common stock, $0.01 par value per share; 150,000,000 shares authorized; 19,565,531 and 18,304,881 issued and outstanding as of June 30, 2017 and December 31, 2016, respectively	196	183
Additional paid-in capital	282,603	280,221
Accumulated deficit	(234,303)	(220,868)
Accumulated other comprehensive loss	(164)	(13)
Total equity attributable to the Company	48,336	59,528
Noncontrolling interests	4,917	4,641
Total equity	53,253	64,169
Total liabilities and equity	72,382	82,807
Series A Convertible Preferred Stock [Member]
Equity
Preferred stock	0	0
Series B Convertible Preferred Stock [Member]
Equity
Preferred stock	0	0
Series C Junior Preferred Stock [Member]
Equity
Preferred stock	0	0
Series D Convertible Preferred Stock [Member]
Equity
Preferred stock	$ 4	$ 5

CONDENSED CONSOLIDATED BALANCE3

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)	Jun. 30, 2017	Dec. 31, 2016
Common stock, par value	$ 0.01	$ 0.01
Common stock, authorized	150,000,000	150,000,000
Common stock, issued	19,565,531	18,304,881
Common stock, outstanding	19,565,531	18,304,881
Series A Convertible Preferred Stock [Member]
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, authorized	500,000	500,000
Preferred stock, issued	6,968	6,968
Preferred stock, outstanding	0	0
Series B Convertible Preferred Stock [Member]
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, authorized	5,000,000	5,000,000
Preferred stock, issued	1,666,667	1,666,667
Preferred stock, outstanding	0	0
Series C Junior Preferred Stock [Member]
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, authorized	300,000	300,000
Preferred stock, issued	0	0
Preferred stock, outstanding	0	0
Series D Convertible Preferred Stock [Member]
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, authorized	500,000	500,000
Preferred stock, issued	475,208	491,427
Preferred stock, outstanding	429,948	491,427
Preferred Stock, Liquidation Preference, Value	$ 20,638	$ 23,588

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
		Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Revenue
Wellness		$ 12,927	$ 0	$ 23,911	$ 0
Technology		3,450	2,450	6,941	3,727
Intellectual property		0	8,900	100	9,650
Total revenue		16,377	11,350	30,952	13,377
Cost of sales
Wellness		10,401	0	19,236	0
Technology		2,690	2,180	5,618	3,304
Intellectual property	[1]	118	4,243	217	4,963
Total cost of sales		13,209	6,423	25,071	8,267
Depreciation, amortization and impairment		3,094	12,329	4,955	13,159
General and administrative	[1]	5,204	2,316	11,539	4,495
Total operating expenses		21,507	21,068	41,565	25,921
Operating loss from continuing operations		(5,130)	(9,718)	(10,613)	(12,544)
Non-operating income (expense), net		(50)	181	61	518
Interest expense		(178)	(272)	(367)	(748)
Extinguishment of debt		0	0	0	(210)
Loss from continuing operations before income taxes		(5,358)	(9,809)	(10,919)	(12,984)
Income tax expense		0	0	(227)	0
Consolidated net loss from continuing operations		(5,358)	(9,809)	(11,146)	(12,984)
Loss from discontinued operations before income taxes		(1,552)	(998)	(2,113)	(1,778)
Income tax expense		0	0	0	0
Net loss from discontinued operations		(1,552)	(998)	(2,113)	(1,778)
Consolidated net loss		(6,910)	(10,807)	(13,259)	(14,762)
Net income attributable to noncontrolling interests		(100)	0	(176)	0
Net loss attributable to the Company		(7,010)	(10,807)	(13,435)	(14,762)
Other comprehensive loss: foreign currency translation				(151)
Comprehensive loss		$ (7,017)	$ (10,807)	$ (13,410)	$ (14,762)
Basic and diluted net loss per share
Loss per share from continuing operations (in dollars per share)		$ (0.28)	$ (0.65)	$ (0.59)	$ (0.89)
Loss per share from discontinued operations (in dollars per share)		(0.08)	(0.07)	(0.11)	(0.12)
Total basic and diluted net loss per share (in dollars per share)		$ (0.36)	$ (0.72)	$ (0.70)	$ (1.01)
Weighted-average number of shares outstanding during the period:
Basic (in shares)		19,310,994	14,993,686	19,178,769	14,576,183
Diluted (in shares)		19,310,994	14,993,686	19,178,769	14,576,183
Includes stock-based compensation expense, as follows:
Total stock-based compensation expense		$ 732	$ 499	$ 1,473	$ 962
General and Administrative [Member]
Includes stock-based compensation expense, as follows:
Total stock-based compensation expense		732	435	1,473	830
Intellectual Property Cost [Member]
Includes stock-based compensation expense, as follows:
Total stock-based compensation expense		0	64	0	132
Discontinued Operations [Member]
Cost of sales
Net loss from discontinued operations		(1,552)	(998)	(2,113)	(1,778)
Other comprehensive loss: foreign currency translation		0	0	0	0
Comprehensive loss		(1,552)	(998)	(2,113)	(1,778)
Continuing Operations [Member]
Cost of sales
Consolidated net loss from continuing operations		(5,358)	(9,809)	(11,146)	(12,984)
Other comprehensive loss: foreign currency translation		(107)	0	(151)	0
Comprehensive loss		$ (5,465)	$ (9,809)	$ (11,297)	$ (12,984)
[1]	Includes stock-based compensation expense, as follows: Intellectual property, General and administrative.

CONDENSED CONSOLIDATED STATEME5

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($) $ in Thousands	Total	Common stock [Member]	Preferred stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Loss [Member]	Total FORM Equity [Member]	Non-controlling Interests [Member]
Balance at Dec. 31, 2015	$ 40,516	$ 132	$ 0	$ 237,246	$ (196,862)	$ 0	$ 40,516	$ 0
Issuance of common stock for repayment of convertible debt and related interest	2,996	18	0	2,978	0	0	2,996	0
Stock-based compensation	962	0	0	962	0	0	962	0
Net loss for the period	(14,762)	0	0	0	(14,762)	0	(14,762)	0
Balance at Jun. 30, 2016	29,712	150	0	241,186	(211,624)	0	29,712	0
Balance at Dec. 31, 2016	64,169	183	5	280,221	(220,868)	(13)	59,528	4,641
Issuance of common stock for services	20	0	0	20	0	0	20	0
Shares of common stock issued for the acquisition of Excalibur	1,809	9	0	1,800	0	0	1,809	0
Decrease in shares of preferred stock issued to XpresSpa sellers	(908)	0	0	(908)	0	0	(908)	0
Conversion of preferred stock to common stock	0	4	(1)	(3)	0	0	0	0
Stock-based compensation	1,473	0	0	1,473	0	0	1,473	0
Net loss for the period	(13,259)	0	0	0	(13,435)	0	(13,435)	176
Foreign currency translation	(151)	0	0	0	0	(151)	(151)	0
Contributions from noncontrolling interests	100	0	0	0	0	0	0	100
Balance at Jun. 30, 2017	$ 53,253	$ 196	$ 4	$ 282,603	$ (234,303)	$ (164)	$ 48,336	$ 4,917

CONDENSED CONSOLIDATED STATEME6

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Cash flows from operating activities
Consolidated net loss	$ (13,259)	$ (14,762)
Items not affecting cash flows
Depreciation and amortization	4,955	1,222
Impairment of intangible assets	0	11,937
Amortization of debt discount and debt issuance costs	0	660
Stock-based compensation	1,473	962
Amendment to warrants as part of debt modification	0	(281)
Extinguishment of debt	0	356
Issuance of shares of common stock for services	20	0
Change in fair value of derivative warrant liabilities and conversion feature	(159)	(87)
Exchange rate loss (gain), net	0	(75)
Changes in current assets and liabilities net of effects of acquisition
Increase in accounts receivable	(1,277)	(139)
Increase in inventory	(1,386)	(32)
Decrease in other current assets and other assets	1,473	443
Increase (decrease) in accounts payable, accrued expenses and other current liabilities	(557)	375
Increase (decrease) in deferred revenue	(52)	146
Decrease in other liabilities	(15)	(246)
Net cash provided by (used in) operating activities - continuing operations	(8,784)	479
Net cash provided by operating activities - discontinued operations	931	219
Net cash provided by (used in) operating activities	(7,853)	698
Cash flows from investing activities
Cash acquired as part of acquisition	26	0
Acquisition of property and equipment	(1,565)	(151)
Acquisition of software	(148)	0
Decrease in deposits	0	2,001
Net cash provided by (used in) investing activities	(1,687)	1,850
Cash flows from financing activities
Repayment of line of credit	(361)	0
Net contributions from noncontrolling interests	100	0
Debt issuance costs	0	(50)
Net cash used in financing activities	(261)	(50)
Effect of exchange rate changes on cash and cash equivalents	(151)	0
Increase (decrease) in cash and cash equivalents	(9,952)	2,498
Cash and cash equivalents at beginning of period	17,910	24,951
Cash and cash equivalents at end of period	7,958	27,449
Cash paid during the period for
Interest	430	40
Noncash investing and financing transactions
Issuance of common stock to repay debt and interest	$ 0	$ 2,996

General

General	6 Months Ended
	Jun. 30, 2017
General [Abstract]
General	FORM Holdings Corp. (“FORM” or the “Company”) has three operating segments: wellness, technology and intellectual property. The Company’s wellness operating segment consists of XpresSpa, which is a leading airport retailer of spa services. XpresSpa is a well-recognized airport spa brand with 52 The Company’s technology operating segment consists of Group Mobile as well as an 11 8.25 As further detailed in Note 10 “Discontinued Operations and Assets and Liabilities Held for Disposal,” during June 2017, the Company concluded that the requirement to report the results of FLI Charge as discontinued operations was triggered. The Company is currently evaluating strategic alternatives with respect to Group Mobile in an attempt to enhance stockholder value. These strategic alternatives may include a possible sale, merger, spin-off or other separation of Group Mobile or other forms of business combinations or strategic transactions. The Company is seeking to enter into one or more strategic transactions involving Group Mobile in the first quarter of 2018. The Company’s intellectual property operating segment is engaged in the monetization of patents related to content and ad delivery, remote monitoring and mobile technologies.

Accounting and Reporting Polici

Accounting and Reporting Policies	6 Months Ended
	Jun. 30, 2017
Accounting Policies [Abstract]
Accounting and Reporting Policies	Note 2. Accounting and Reporting Policies The accompanying interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) for interim financial information and the instructions to Rule 10-01 of Regulation S-X, and should be read in conjunction with the Company's Annual Report on Form 10-K for the year ended December 31, 2016. All adjustments that, in the opinion of management, are necessary for a fair presentation for the periods presented have been reflected by the Company. Such adjustments are of a normal, recurring nature. The results of operations for the three and six-month periods ended June 30, 2017 are not necessarily indicative of the results that may be expected for the entire fiscal year or for any other interim period. All significant intercompany balances and transactions have been eliminated in consolidation. The preparation of the accompanying condensed consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses for the periods presented. Actual results may differ from such estimates. Significant items subject to such estimates and assumptions include the Company’s intangible assets, the useful lives of the Company’s intangible assets, the valuation of the Company’s derivative warrants, the valuation of stock-based compensation, deferred tax assets and liabilities, income tax uncertainties, and other contingencies. The Company recognizes revenue for the wellness operating segment from the sale of XpresSpa products and services at the point of sale, net of discounts and applicable sales taxes. Revenues from the XpresSpa wholesale and e-commerce businesses are recorded at the time goods are shipped. The Company excludes all sales taxes assessed to its customers. Sales taxes assessed on revenues are included in accounts payable, accrued expenses and other current liabilities in the condensed consolidated balance sheets until remitted to the state agencies. The Company records revenue from product sales in the technology operating segment when title and risk of loss are passed to the customer, there is persuasive evidence of an arrangement for sale, delivery has occurred, the sales price is fixed or determinable, and collectability is reasonably assured. The Company’s shipping terms typically specify F.O.B. destination, at which time title and risk of loss have passed to the customer. At the time of sale of hardware products, the Company records an estimate for sales returns and allowances based on historical experience. Hardware products sold by the Company are warranted by the vendor. The Company has drop-shipment arrangements with many of its hardware vendors and suppliers to deliver products directly to customers. Revenue for drop-shipment arrangements is recorded on a gross basis upon delivery to the customer with contract terms that typically specify F.O.B. destination. Revenue is recognized on a gross basis, as the Company is the principal in the transaction, as the primary obligor in the arrangement, assumes the inventory risk if the product is returned by the customer, sets the price of the product to the customer, assumes credit risk for the amounts invoiced, and works closely with the customers to determine their hardware specifications. Freight billed to customers is recognized as net product revenue and the related freight costs as a cost of sales. On certain occasions, the Company’s technology operating segment will enter into a bill and hold arrangement with a customer. When this occurs, the Company makes a determination as to when it will be the proper time to recognize revenue. In doing so, the Company takes the following into consideration: • whether the risks of ownership have passed to the customer; • the customer must have made a fixed commitment to purchase the goods; • the customer must request and have a substantial business purpose for ordering on a bill and hold basis; • there must be a fixed schedule for delivery that is reasonable and consistent with the customer’s business purpose; • the Company cannot retain any specific performance obligations that would make the earnings process incomplete; • the goods must be segregated from remaining inventory (i.e., they cannot be used to fill orders for others); and • the goods must be complete and ready for shipment. For multiple-element arrangements in the Company’s technology operating segment that include hardware products, services and maintenance, the Company allocates revenue to all deliverables based on their relative selling prices. In such circumstances, the Company uses a hierarchy to determine the selling price to be used for allocating revenue to deliverables: (i) vendor-specific objective evidence of fair value (“VSOE”), (ii) third-party evidence of selling price (“TPE”) and (iii) best estimate of selling price (“ESP”). VSOE generally exists only when the Company sells the deliverable separately and is the price actually charged by the Company for that deliverable. ESPs reflect the Company’s best estimates of what the selling prices of elements would be if they were sold regularly on a stand-alone basis. The Company allocates revenue to all deliverables based on the VSOE of each element, and if VSOE does not exist revenue is recognized when elements lacking VSOE are delivered. Revenue from patent licensing is recognized if collectability is reasonably assured, persuasive evidence of an arrangement exists, the sales price is fixed or determinable and delivery of the service has been rendered. Currently, revenue arrangements related to intellectual property provide for the payment of contractually determined fees and other consideration for the grant of certain intellectual property rights related to the Company’s patents. These rights typically include some combination of the following: (i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patents, (ii) the release of the licensee from certain claims, and (iii) the dismissal of any pending litigation. The intellectual property rights granted typically extend until the expiration of the related patents. Pursuant to the terms of these agreements, the Company has no further obligation with respect to the grant of the non-exclusive retroactive and future licenses, covenants-not-to-sue, releases, and other deliverables, including no express or implied obligation on the Company’s part to maintain or upgrade the related technology, or provide future support or services. Generally, the agreements provide for the grant of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon execution of the agreement, or upon receipt of the upfront payment. As such, the earnings process is complete and revenue is recognized upon the execution of the agreement, upon receipt of the upfront fee, and when all other revenue recognition criteria have been met. Cost of sales for the Company’s wellness operating segment consists of store-level costs. Store-level costs include all costs that are directly attributable to the store operations and include: • payroll and related benefits for store operations and store-level management; • rent, percentage rent and occupancy costs; • the cost of merchandise; • freight, shipping and handling costs; • production costs; • inventory shortage and valuation adjustments, including purchase price allocation increase in fair values which was recorded as part of acquisition; and • costs associated with sourcing operations. Cost of sales for the Company’s technology operating segment includes costs to acquire or manufacture goods for inventory. Cost of sales for the Company’s intellectual property operating segment mainly includes expenses incurred in connection with the Company’s patent licensing and enforcement activities, patent-related legal expenses paid to external patent counsel (including contingent legal fees), licensing and enforcement related research, consulting and other expenses paid to third parties, as well as related internal payroll expenses. ASU No. 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business In January 2017, the FASB issued Accounting Standards Update No. 2017-01 (“ASU 2017-01”) “Business Combinations (Topic 805): Clarifying the Definition of a Business.” ASU 2017-01 provides guidance to evaluate whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. If substantially all of the fair value of the gross assets acquired (or disposed of) is concentrated in a single asset or a group of similar assets, the assets acquired (or disposed of) are not considered a business. The Company adopted ASU 2017-01 as of January 1, 2017 on a prospective basis. ASU No. 2017-04, Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment In January 2017, the FASB issued Accounting Standards Update No. 2017-04 (“ASU 2017-04”) “Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment.” ASU 2017-04 eliminates step two of the goodwill impairment test and specifies that goodwill impairment should be measured by comparing the fair value of a reporting unit with its carrying amount. Additionally, the amount of goodwill allocated to each reporting unit with a zero or negative carrying amount of net assets should be disclosed. ASU 2017-04 is effective for annual or interim goodwill impairment tests performed in fiscal years beginning after December 15, 2019; early adoption is permitted. The Company currently anticipates that the adoption of ASU 2017-04 will not have a material impact on its consolidated financial statements. ASU No. 2017-09, Stock Compensation (Topic 718): Scope of Modification Accounting In May 2017, the FASB issued Accounting Standards Update No. 2017-09 (“ASU 2017-09”) “Stock Compensation (Topic 718): Scope of Modification Accounting.” ASU 2017-09 provides guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic 718. The current disclosure requirements in Topic 718 apply regardless of whether an entity is required to apply modification accounting under the amendments in this update. ASU 2017-09 is effective for annual periods, and interim periods within those annual periods, beginning after December 15, 2017; early adoption is permitted. The Company is currently in the process of evaluating the potential impact of the adoption on its consolidated financial statements. Certain balances have been reclassified to conform to presentation requirements, including presentation of discontinued operations and assets and liabilities held for disposal with respect to the Company’s FLI Charge business (refer to Note 10), as well as consistent presentation of cost of sales and general and administrative expenses to align presentation for operating segments.

Net Loss per Share of Common St

Net Loss per Share of Common Stock	6 Months Ended
	Jun. 30, 2017
Earnings Per Share, Basic and Diluted [Abstract]
Net Loss per Common Share	Note 3. Net Loss per Share of Common Stock Basic net loss per share is computed by dividing the net loss for the period by the weighted-average number of shares of common stock outstanding during the period. Diluted net loss per share is computed by dividing the net loss for the period by the weighted-average number of shares of common stock plus dilutive potential common stock considered outstanding during the period. However, as the Company generated a net loss in all periods presented, some potentially dilutive securities, including certain warrants and stock options, were not reflected in diluted net loss per share because the impact of such instruments was anti-dilutive. Three months ended June 30, Six months ended June 30, 2017 2016 2017 2016 Basic numerator: Net loss from continuing operations attributable to shares of common stock $ (5,458) $ (9,809) $ (11,322) $ (12,984) Net loss from discontinued operations attributable to shares of common stock (1,552) (998) (2,113) (1,778) Net loss attributable to shares of common stock $ (7,010) $ (10,807) $ (13,435) $ (14,762) Basic denominator: Basic shares of common stock outstanding 19,310,994 14,993,686 19,178,769 14,576,183 Basic loss per share of common stock from continuing operations $ (0.28) $ (0.65) $ (0.59) $ (0.89) Basic loss per share of common stock from discontinued operations (0.08) (0.07) (0.11) (0.12) Basic net loss per share of common stock $ (0.36) $ (0.72) $ (0.70) $ (1.01) Diluted numerator: Net loss from continuing operations attributable to shares of common stock $ (5,458) $ (9,809) $ (11,322) $ (12,984) Net loss from discontinued operations attributable to shares of common stock (1,552) (998) (2,113) (1,778) Net loss attributable to shares of common stock $ (7,010) $ (10,807) $ (13,435) $ (14,762) Diluted denominator: Diluted shares of common stock outstanding 19,310,994 14,993,686 19,178,769 14,576,183 Diluted loss per share of common stock from continuing operations $ (0.28) $ (0.65) $ (0.59) $ (0.89) Diluted loss per share of common stock from discontinued operations (0.08) (0.07) (0.11) (0.12) Diluted net loss per share of common stock $ (0.36) $ (0.72) $ (0.70) $ (1.01) Net loss per share data presented excludes from the calculation of diluted net loss the following potentially dilutive securities, as they had an anti-dilutive impact: Both vested and unvested options to purchase an equal number of shares of common stock of the Company 5,135,399 1,492,434 5,135,399 1,492,434 Unvested restricted stock units (“RSUs”) to issue an equal number of shares of common stock of the Company 400,942 7,808 400,942 7,808 Warrants to purchase an equal number of shares of common stock of the Company 3,430,877 1,006,679 3,430,877 1,006,679 Preferred stock on an as converted basis 3,439,587 — 3,620,626 — Conversion feature of senior secured notes — — — 159,462 Total number of potentially dilutive instruments, excluded from the calculation of net loss per share 12,406,805 2,506,921 12,587,844 2,666,383

Business Combinations

Business Combinations	6 Months Ended
	Jun. 30, 2017
Business Combinations [Abstract]
Business Combinations	Note 4. Business Combinations XpresSpa During the three months ended June 30, 2017, the Company learned new information about legal and other professional costs which existed as of the acquisition date of XpresSpa. As a result, the Company and the sellers of XpresSpa (the “XpresSpa Sellers”) agreed to reduce the total amount of Series D Convertible Preferred Stock (“FORM Preferred Stock”), which was previously issued to the XpresSpa Sellers in conjunction with the acquisition of XpresSpa. The Company reduced the number of the FORM Preferred Stock by 16,219 908 Additionally, during the three months ended June 30, 2017, certain XpresSpa Sellers converted 45,260 362,077 0.01 As a result of these events, the total number of shares of FORM Preferred Stock was reduced from 491,427 429,948 23,588 20,638 Group Mobile On February 2, 2017, the Company acquired Excalibur, which is an end-to-end solutions provider of mobile hardware devices, wireless network security, data networking, telephony and mobile application development and software solutions. Following the acquisition, Excalibur was merged with Group Mobile within the Company’s technology operating segment. In consideration for the acquisition, the Company issued 888,573 0.01 The fair value of the total purchase price is $ 2,125 316 1,809 Assets acquired and liabilities assumed were recorded at their fair values as of the acquisition date. The purchase price for the acquisition was allocated to the net tangible and intangible assets based on their fair values as of the acquisition date. The excess of the purchase price over the net tangible assets and intangible assets was recorded as goodwill. The table below presents preliminary allocation of the purchase price: Fair Value Assets Current assets (including cash of $26) $ 628 Deferred tax assets 29 Property and equipment 21 Intangible assets 556 Goodwill 2,320 Total assets 3,554 Liabilities Accounts payable and accrued expenses 1,214 Deferred tax liabilities 215 Total liabilities 1,429 Net assets, fair value $ 2,125 The allocation of the purchase price was based upon a preliminary valuation performed using the Company's estimates and assumptions, which are subject to change within the measurement period (up to one year from the acquisition date).

Segment Information

Segment Information	6 Months Ended
	Jun. 30, 2017
Segment Reporting [Abstract]
Segment Information	Note 5. Segment Information The Company’s operating segments are defined as components of an enterprise about which separate financial information is available that is regularly evaluated by the enterprise’s chief operating decision maker (“CODM”) in deciding how to allocate resources and in assessing performance. The Company concluded that it conducts its business through three operating segments, which are also its reportable segments: • wellness (XpresSpa); • technology (Group Mobile); and • intellectual property Segment operating results reflect losses before corporate and unallocated shared expenses, interest expense and income taxes. Corporate and unallocated shared expenses principally consist of costs for corporate functions, rent for office space, stock-based compensation, executive management and certain unallocated administrative support functions. Three months ended June 30, Six months ended June 30, 2017 2016 2017 2016 Revenue Wellness $ 12,927 $ — $ 23,911 $ — Technology 3,450 2,450 6,941 3,727 Intellectual property — 8,900 100 9,650 Total revenue 16,377 11,350 30,952 13,377 Cost of sales Wellness 10,401 — 19,236 — Technology 2,690 2,180 5,618 3,304 Intellectual property 118 4,243 217 4,963 Total cost of sales 13,209 6,423 25,071 8,267 Segment operating loss Wellness (1,992) — (4,363) — Technology (742) (327) (1,656) (648) Intellectual property (126) (7,577) (131) (8,280) Corporate (2,270) (1,814) (4,463) (3,616) Total segment operating loss (5,130) (9,718) (10,613) (12,544) Corporate non-operating expense, net (228) (91) (306) (440) Loss from continuing operations before income taxes $ (5,358) $ (9,809) $ (10,919) $ (12,984) June 30, 2017 December 31, 2016 Assets Wellness $ 53,137 $ 57,527 Technology 4,602 8,634 Intellectual property 825 940 Corporate 13,818 15,706 Total assets $ 72,382 $ 82,807 General and administrative costs are allocated among the operating segments and non-operating corporate segment. The non-operating corporate segment does not have any revenue, but does incur expenses such as compensation expenses, rent and infrastructure costs. The non-operating corporate segment’s assets are mainly comprised of cash. The Company currently operates in two geographical regions: United States and all other countries. The following table represents the geographical revenue, regional operating loss, and total asset information as of and for the three and six months ended June 30, 2017 and 2016. There were no concentrations of geographical revenue, regional operating loss or total assets related to any single foreign country that were material to the Company’s condensed consolidated financial statements. Three months ended June 30, Six months ended June 30, 2017 2016 2017 2016 Revenue United States $ 15,115 $ 11,350 $ 28,574 $ 13,377 All other countries 1,262 — 2,378 — Total revenue 16,377 11,350 30,952 13,377 Cost of sales United States 12,384 6,423 23,569 8,267 All other countries 825 — 1,502 — Total cost of sales 13,209 6,423 25,071 8,267 Segment operating income (loss) United States (5,636) (9,713) (11,309) (12,541) All other countries 506 (5) 696 (3) Total segment operating income (loss) (5,130) (9,718) (10,613) (12,544) Corporate non-operating expense, net (228) (91) (306) (440) Loss from continuing operations before income taxes $ (5,358) $ (9,809) $ (10,919) $ (12,984) June 30, 2017 December 31, 2016 Assets United States $ 70,380 $ 80,053 All other countries 2,002 2,754 Total assets $ 72,382 $ 82,807

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Jun. 30, 2017
Fair Value Disclosures [Abstract]
Fair Value Measurements	Note 6. Fair Value Measurements Derivative Warrant Liabilities Fair value measurement at reporting date using Quoted prices in active markets Significant other Significant for identical observable unobservable Balance assets (Level 1) inputs (Level 2) inputs (Level 3) June 30, 2017: May 2015 Warrants $ 100 $ — $ — $ 100 December 31, 2016: May 2015 Warrants $ 259 $ — $ — $ 259 The Company measures its derivative warrant liabilities at fair value. The May 2015 Warrants were classified within Level 3 because they were valued using the Black-Scholes-Merton model, which utilizes significant inputs that are unobservable in the market. These derivative warrant liabilities were initially measured at fair value and are marked to market at each balance sheet date. In addition to the above, the Company’s financial instruments as of June 30, 2017 and December 31, 2016 consisted of cash and cash equivalents, receivables, accounts payable and Debt. The carrying amounts of all the aforementioned financial instruments approximate fair value because of the short-term maturities of these instruments. May 2015 Warrants December 31, 2016 $ 259 Decrease in fair value of the derivative warrant liabilities (159) June 30, 2017 $ 100 Valuation processes for Level 3 Fair Value Measurements Fair value measurement of the derivative warrant liabilities falls within Level 3 of the fair value hierarchy. June 30, 2017: Description Valuation technique Unobservable inputs Range May 2015 Warrants Black-Scholes-Merton Volatility 42.12 % Risk free interest rate 1.51 % Expected term, in years 2.84 Dividend yield 0.00 % December 31, 2016: Description Valuation technique Unobservable inputs Range May 2015 Warrants Black-Scholes-Merton Volatility 45.15 % Risk-free interest rate 1.57 % Expected term, in years 3.34 Dividend yield 0.00 % Sensitivity of Level 3 measurements to changes in significant unobservable inputs The inputs to estimate the fair value of the Company’s derivative warrant liabilities were the current market price of the Company’s common stock, the exercise price of the derivative warrant liabilities, their remaining expected term, the volatility of the Company’s common stock price and the risk-free interest rate over the expected term. Significant changes in any of those inputs in isolation can result in a significant change in the fair value measurement. Generally, an increase in the market price of the Company’s shares of common stock, an increase in the volatility of the Company’s shares of common stock, and an increase in the remaining term of the derivative warrant liabilities would each result in a directionally similar change in the estimated fair value of the Company’s derivative warrant liabilities. Such changes would increase the associated liability while decreases in these assumptions would decrease the associated liability. An increase in the risk-free interest rate or a decrease in the differential between the derivative warrant liabilities’ exercise price and the market price of the Company’s shares of common stock would result in a decrease in the estimated fair value measurement and thus a decrease in the associated liability. The Company has not, and does not plan to, declare dividends on its common stock and, as such, there is no change in the estimated fair value of the derivative warrant liabilities due to the dividend assumption. Other Fair Value Measurements Fair value measurement at reporting date using Quoted prices in active markets Significant other Significant for identical observable unobservable Balance assets (Level 1) inputs (Level 2) inputs (Level 3) June 30, 2017: Contingent consideration $ 316 $ — $ — $ 316 FORM Preferred Stock $ 908 $ — $ — $ 908 The purchase value of the contingent consideration assumed by the Company following the acquisition of Excalibur and the fair value of the decrease in shares of FORM Preferred Stock issued to the XpresSpa Sellers were determined using the Monte-Carlo simulation and, as such, were classified as Level 3 of the fair value hierarchy. The fair value measurements are evaluated by management to ensure that changes are consistent with expectations of management based upon the sensitivity and nature of the inputs. Valuation processes for Level 3 Fair Value Measurements Description Valuation technique Variables Range FORM Preferred Stock Monte-Carlo Share price as of the Valuation Date $ 1.95 Volatility 46.0 % Risk free interest rate 2.22 % Additionally, the Monte-Carlo simulation used the value of the underlying equity value issued to XpresSpa Sellers on the date of the XpresSpa acquisition, December 23, 2016, which is comprised of the aggregation of the fair value of the shares of the Company’s common stock, shares of FORM Preferred Stock and warrants.

Stock-based Compensation

Stock-based Compensation	6 Months Ended
	Jun. 30, 2017
Share-based Compensation [Abstract]
Stock-based Compensation	Note 7. Stock-based Compensation As of June 30, 2017, 1,258,603 shares of the Company’s common stock were available for future grants under the Company’s 2012 Employee, Director and Consultant Equity Incentive Plan. Total stock-based compensation expense for the six-month periods ended June 30, 2017 and 2016 was $ 1,473 962 732 499 The following table illustrates the options granted during the six-month period ended June 30, 2017. Assumptions used in Black- No. of Exercise Fair value at Scholes option pricing Title Grant date options price grant date Vesting terms model Directors, management, and January 2017 1,545,000 $2.12 – $2.15 $0.89 – $0.96 Over 1 year for directors; Over 3 years Volatility: 44.27% – 44.90% employees for management and employees Risk free interest rate: 1.95% – 2.16% Expected term, in years: 5.29 – 5.79 Dividend yield: 0.00% Title Grant date No. of RSUs Fair value at grant date Vesting term Management and employees January 2017 400,942 $ 2.12 Over 1 year period, vesting on 1 year anniversary of grant date RSUs Options Weighted Weighted Weighted average average average No. of grant date No. of exercise Exercise grant date RSUs fair value options price price range fair value Outstanding as of January 1, 2017 — — 3,679,101 $ 7.60 $ 1.55 – 55.00 $ 5.41 Granted 400,942 $ 2.12 1,545,000 $ 2.12 $ 2.12 – 2.15 $ 0.93 Vested/Exercised — — — — — — Forfeited — — (72,334) $ 24.80 $ 1.55 – 37.20 $ 16.81 Expired — — (16,368) $ 43.66 $ 9.94 – 55.00 $ 22.02 Outstanding as of June 30, 2017 400,942 $ 2.12 5,135,399 $ 5.60 $ 1.55 – 41.00 $ 3.85 Exercisable as of June 30, 2017 — 2,459,982 $ 9.72 $ 1.55 – 41.00 On January 20, 2017, the Company entered into amended employment agreements with its named executive officers. Under the terms of certain of these agreements, certain of these officers are entitled to a percentage of the amount equal to the total amount of cash and the fair market value of all noncash consideration paid or payable to the Company or its stockholders in connection with an initial public offering or a change of control of certain subsidiaries of the Company. The amended employment agreements also allow for the granting of equity awards to certain officers in connection with an initial public offering of certain subsidiaries of the Company. The Company did not recognize tax benefits related to its stock-based compensation as there is a full valuation allowance recorded.

Income Taxes

Income Taxes	6 Months Ended
	Jun. 30, 2017
Income Tax Disclosure [Abstract]
Income Taxes	Note 8. Income Taxes The Company’s provision for income taxes consists of federal, state, local, and foreign taxes in amounts necessary to align the Company’s year-to-date provision for income taxes with the effective tax rate that the Company expects to achieve for the full year. Each quarter, the Company updates its estimate of the annual effective tax rate and records cumulative adjustments as deemed necessary. The income tax provisions for the six months ended June 30, 2017 reflect an estimated global annual effective tax rate of approximately -3.96% from continuing operations. Discontinued operations for the six months ended June 30, 2017 reflect an annual effective tax rate of 0.58 As of June 30, 2017, deferred tax assets generated from the Company’s U.S. activities were offset by a valuation allowance because realization depends on generating future taxable income, which, in the Company’s estimation, is not more likely than not to be generated before such net operating loss carryforwards expire. The Company expects its effective tax rate for its current fiscal year to be significantly lower than the statutory rate as a result of a full valuation allowance; therefore, any loss before income taxes does not generate a corresponding income tax benefit. Income tax expense for the six months ended June 30, 2017 of approximately $ 227

Related Parties Transactions

Related Parties Transactions	6 Months Ended
	Jun. 30, 2017
Related Party Transactions [Abstract]
Related Party Transactions Disclosure	Note 9. Related Parties Transactions On April 22, 2015, XpresSpa entered into a credit agreement and secured promissory note (the “Debt”) with Rockmore Investment Master Fund Ltd. (“Rockmore”) that was amended on August 8, 2016. Rockmore is an investment entity controlled by the Company’s board member, Bruce T. Bernstein. The Debt had an outstanding balance of $ 6,500 430 365 May 1, 2018 May 1, 2019 In addition, the Company paid $ 212

Discontinued Operations and Ass

Discontinued Operations and Assets and Liabilities Held For Disposal	6 Months Ended
	Jun. 30, 2017
Discontinued Operations and Disposal Groups [Abstract]
Discontinued Operations and Assets and Liabilities Held For Disposal	Note 10. Discontinued Operations and Assets and Liabilities Held For Disposal During June 2017, the Company concluded that the requirement to report the results of FLI Charge, a wholly-owned subsidiary included in its technology operating segment, as discontinued operations was triggered. The Company is currently negotiating the terms of an agreement to sell FLI Charge to a third-party investor in exchange for a minority investment in the form of shares of preferred stock in the newly created entity, which will own and operate FLI Charge. The Company will not be providing any continued management or financing support to FLI Charge. The transaction is expected to close in the third quarter of 2017. In connection with this agreement, a non-cash impairment loss of $ 1,092 : Three months ended June 30, Six months ended June 30, 2017 2016 2017 2016 Revenue $ 19 13 53 $ 29 Cost of sales (36) — (68) (2) Depreciation, amortization and impairment (1,130) (21) (1,168) (42) General and administrative (405) (990) (930) (1,763) Loss from discontinued operations before income taxes (1,552) (998) (2,113) (1,778) Income tax expense — — — — Net loss from discontinued operations $ (1,552) $ (998) $ (2,113) $ (1,778) In addition, the following table presents the carrying amounts of the major classes of assets and liabilities held for sale as of June 30, 2017 and December 31, 2016, as presented in the condensed consolidated balance sheets. June 30, 2017 December 31, 2016 Accounts receivable, net $ 39 $ 45 Inventory 208 53 Other current assets 24 92 Property and equipment, net 196 183 Intangible assets, net — 377 Goodwill — 757 Assets held for disposal $ 467 $ 1,507 Accounts payable, accrued expenses and other current liabilities $ 88 $ 196 Deferred revenue 9 10 Liabilities held for disposal $ 97 $ 206

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2017
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 11. Commitments and Contingencies Litigation and legal proceedings Certain of the Company’s outstanding legal matters include speculative claims for substantial or indeterminate amounts of damages. The Company regularly evaluates developments in its legal matters that could affect the amount of any potential liability and makes adjustments as appropriate. Significant judgment is required to determine both the likelihood of there being a liability and the estimated amount of a loss related to such matters. With respect to the Company’s outstanding legal matters, based on its current knowledge, the Company’s management believes that the amount or range of a potential loss will not, either individually or in the aggregate, have a material adverse effect on its business, consolidated financial position, results of operations or cash flows. However, the outcome of such legal matters is inherently unpredictable and subject to significant uncertainties. The Company evaluated the matters described below, and assessed the probability and likelihood of the occurrence of liability. Based on management’s estimates, the Company recorded $ 650 The Company expenses legal fees in the period in which they are incurred. Cordial Effective October 2014, XpresSpa terminated its former Airport Concession Disadvantaged Business Enterprise (“ACDBE”) partner, Cordial Endeavor Concessions of Atlanta, LLC (“Cordial”), in several store locations at Hartsfield-Jackson Atlanta International Airport. On January 3, 2017, XpresSpa filed a lawsuit in the Supreme Court of the State of New York, County of New York against Cordial and several related parties. The lawsuit alleges breach of contract, unjust enrichment, breach of fiduciary duty, fraudulent inducement, fraudulent concealment, tortious interference, and breach of good faith and fair dealing related to XpresSpa’s former partnership with Cordial as XpresSpa’s ACDBE partner in several store locations at Hartsfield-Jackson Atlanta International Airport (the “Cordial Litigation”). On March 3, 2017, XpresSpa filed a first amended complaint against Cordial. On April 5, 2017, Cordial filed a motion to dismiss the Cordial Litigation. On January 4, 2017, XpresSpa filed a lawsuit in the United States District Court for the Southern District of New York against its former attorney, Kevin Ross, and his law firm, alleging malpractice, unjust enrichment, breach of fiduciary duty, fraudulent inducement, fraudulent concealment, tortious interference, and promissory estoppel related to XpresSpa’s former partnership with Cordial, as well as XpresSpa’s engagement of Kevin Ross as its attorney (the “Ross Litigation”). On March 17, 2017, XpresSpa filed a First Amended Complaint against the defendants. On June 2, 2017, the Ross Defendants filed their answer. Both the Cordial Litigation and Ross Litigation are pending before the respective courts. In re Chen et al. On March 16, 2015, four former employees of XpresSpa who worked at locations in John F. Kennedy International Airport and LaGuardia Airport filed a putative class and collective action wage-hour litigation in the United States District Court for the Eastern District of New York, claiming that they and other spa technicians were misclassified, and that overtime was unpaid. On September 23, 2016, the Court conditionally certified the class. The parties held a mediation on February 28, 2017 and reached an agreement on a settlement in principle. The parties are in the process of finalizing a formal settlement agreement, and preparing a motion to the Court for preliminary approval of a classwide settlement. Other XpresSpa is involved in various other claims and legal actions that arise in the ordinary course of business. The Company does not believe that the ultimate resolution of these actions will have a material adverse effect on XpresSpa’s financial position, results of operations, liquidity, or capital resources. However, a significant increase in the number of these claims, or one or more successful claims under which the Company incurs greater liabilities than the Company currently anticipates, could materially and adversely affect the Company’s business, financial condition, results of operations and cash flows. The Company’s intellectual property operating segment is engaged in litigation, for which no liability is recorded, as the Company does not expect a material negative outcome.

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2017
Subsequent Events [Abstract]
Subsequent Events	Note 12. Subsequent Events On July 26, 2017, the Company entered into an underwriting agreement (the “Underwriting Agreement”) with Roth Capital Partners, LLC, acting as the representative of the several underwriters named therein (collectively, the “Underwriters”), relating to the issuance and sale (the “Offering”) of 6,900,000 900,000 1.10 1.023 6,700

Accounting and Reporting Poli19

Accounting and Reporting Policies (Policies)	6 Months Ended
	Jun. 30, 2017
Accounting Policies [Abstract]
Basis of presentation and principles of consolidation	(a) Basis of presentation and principles of consolidation The accompanying interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) for interim financial information and the instructions to Rule 10-01 of Regulation S-X, and should be read in conjunction with the Company's Annual Report on Form 10-K for the year ended December 31, 2016. All adjustments that, in the opinion of management, are necessary for a fair presentation for the periods presented have been reflected by the Company. Such adjustments are of a normal, recurring nature. The results of operations for the three and six-month periods ended June 30, 2017 are not necessarily indicative of the results that may be expected for the entire fiscal year or for any other interim period. All significant intercompany balances and transactions have been eliminated in consolidation.
Use of estimates	(b) Use of estimates The preparation of the accompanying condensed consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses for the periods presented. Actual results may differ from such estimates. Significant items subject to such estimates and assumptions include the Company’s intangible assets, the useful lives of the Company’s intangible assets, the valuation of the Company’s derivative warrants, the valuation of stock-based compensation, deferred tax assets and liabilities, income tax uncertainties, and other contingencies.
Revenue recognition	(c) Revenue recognition The Company recognizes revenue for the wellness operating segment from the sale of XpresSpa products and services at the point of sale, net of discounts and applicable sales taxes. Revenues from the XpresSpa wholesale and e-commerce businesses are recorded at the time goods are shipped. The Company excludes all sales taxes assessed to its customers. Sales taxes assessed on revenues are included in accounts payable, accrued expenses and other current liabilities in the condensed consolidated balance sheets until remitted to the state agencies. The Company records revenue from product sales in the technology operating segment when title and risk of loss are passed to the customer, there is persuasive evidence of an arrangement for sale, delivery has occurred, the sales price is fixed or determinable, and collectability is reasonably assured. The Company’s shipping terms typically specify F.O.B. destination, at which time title and risk of loss have passed to the customer. At the time of sale of hardware products, the Company records an estimate for sales returns and allowances based on historical experience. Hardware products sold by the Company are warranted by the vendor. The Company has drop-shipment arrangements with many of its hardware vendors and suppliers to deliver products directly to customers. Revenue for drop-shipment arrangements is recorded on a gross basis upon delivery to the customer with contract terms that typically specify F.O.B. destination. Revenue is recognized on a gross basis, as the Company is the principal in the transaction, as the primary obligor in the arrangement, assumes the inventory risk if the product is returned by the customer, sets the price of the product to the customer, assumes credit risk for the amounts invoiced, and works closely with the customers to determine their hardware specifications. Freight billed to customers is recognized as net product revenue and the related freight costs as a cost of sales. On certain occasions, the Company’s technology operating segment will enter into a bill and hold arrangement with a customer. When this occurs, the Company makes a determination as to when it will be the proper time to recognize revenue. In doing so, the Company takes the following into consideration: • whether the risks of ownership have passed to the customer; • the customer must have made a fixed commitment to purchase the goods; • the customer must request and have a substantial business purpose for ordering on a bill and hold basis; • there must be a fixed schedule for delivery that is reasonable and consistent with the customer’s business purpose; • the Company cannot retain any specific performance obligations that would make the earnings process incomplete; • the goods must be segregated from remaining inventory (i.e., they cannot be used to fill orders for others); and • the goods must be complete and ready for shipment. For multiple-element arrangements in the Company’s technology operating segment that include hardware products, services and maintenance, the Company allocates revenue to all deliverables based on their relative selling prices. In such circumstances, the Company uses a hierarchy to determine the selling price to be used for allocating revenue to deliverables: (i) vendor-specific objective evidence of fair value (“VSOE”), (ii) third-party evidence of selling price (“TPE”) and (iii) best estimate of selling price (“ESP”). VSOE generally exists only when the Company sells the deliverable separately and is the price actually charged by the Company for that deliverable. ESPs reflect the Company’s best estimates of what the selling prices of elements would be if they were sold regularly on a stand-alone basis. The Company allocates revenue to all deliverables based on the VSOE of each element, and if VSOE does not exist revenue is recognized when elements lacking VSOE are delivered. Revenue from patent licensing is recognized if collectability is reasonably assured, persuasive evidence of an arrangement exists, the sales price is fixed or determinable and delivery of the service has been rendered. Currently, revenue arrangements related to intellectual property provide for the payment of contractually determined fees and other consideration for the grant of certain intellectual property rights related to the Company’s patents. These rights typically include some combination of the following: (i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patents, (ii) the release of the licensee from certain claims, and (iii) the dismissal of any pending litigation. The intellectual property rights granted typically extend until the expiration of the related patents. Pursuant to the terms of these agreements, the Company has no further obligation with respect to the grant of the non-exclusive retroactive and future licenses, covenants-not-to-sue, releases, and other deliverables, including no express or implied obligation on the Company’s part to maintain or upgrade the related technology, or provide future support or services. Generally, the agreements provide for the grant of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon execution of the agreement, or upon receipt of the upfront payment. As such, the earnings process is complete and revenue is recognized upon the execution of the agreement, upon receipt of the upfront fee, and when all other revenue recognition criteria have been met.
Cost of Sales	(d) Cost of sales Cost of sales for the Company’s wellness operating segment consists of store-level costs. Store-level costs include all costs that are directly attributable to the store operations and include: • payroll and related benefits for store operations and store-level management; • rent, percentage rent and occupancy costs; • the cost of merchandise; • freight, shipping and handling costs; • production costs; • inventory shortage and valuation adjustments, including purchase price allocation increase in fair values which was recorded as part of acquisition; and • costs associated with sourcing operations. Cost of sales for the Company’s technology operating segment includes costs to acquire or manufacture goods for inventory. Cost of sales for the Company’s intellectual property operating segment mainly includes expenses incurred in connection with the Company’s patent licensing and enforcement activities, patent-related legal expenses paid to external patent counsel (including contingent legal fees), licensing and enforcement related research, consulting and other expenses paid to third parties, as well as related internal payroll expenses.
Recently adopted accounting pronouncements	ASU No. 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business In January 2017, the FASB issued Accounting Standards Update No. 2017-01 (“ASU 2017-01”) “Business Combinations (Topic 805): Clarifying the Definition of a Business.” ASU 2017-01 provides guidance to evaluate whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. If substantially all of the fair value of the gross assets acquired (or disposed of) is concentrated in a single asset or a group of similar assets, the assets acquired (or disposed of) are not considered a business. The Company adopted ASU 2017-01 as of January 1, 2017 on a prospective basis.
Recent issued accounting pronouncements not yet adopted	ASU No. 2017-04, Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment In January 2017, the FASB issued Accounting Standards Update No. 2017-04 (“ASU 2017-04”) “Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment.” ASU 2017-04 eliminates step two of the goodwill impairment test and specifies that goodwill impairment should be measured by comparing the fair value of a reporting unit with its carrying amount. Additionally, the amount of goodwill allocated to each reporting unit with a zero or negative carrying amount of net assets should be disclosed. ASU 2017-04 is effective for annual or interim goodwill impairment tests performed in fiscal years beginning after December 15, 2019; early adoption is permitted. The Company currently anticipates that the adoption of ASU 2017-04 will not have a material impact on its consolidated financial statements. ASU No. 2017-09, Stock Compensation (Topic 718): Scope of Modification Accounting In May 2017, the FASB issued Accounting Standards Update No. 2017-09 (“ASU 2017-09”) “Stock Compensation (Topic 718): Scope of Modification Accounting.” ASU 2017-09 provides guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic 718. The current disclosure requirements in Topic 718 apply regardless of whether an entity is required to apply modification accounting under the amendments in this update. ASU 2017-09 is effective for annual periods, and interim periods within those annual periods, beginning after December 15, 2017; early adoption is permitted. The Company is currently in the process of evaluating the potential impact of the adoption on its consolidated financial statements.
Reclassification	(g) Reclassification Certain balances have been reclassified to conform to presentation requirements, including presentation of discontinued operations and assets and liabilities held for disposal with respect to the Company’s FLI Charge business (refer to Note 10), as well as consistent presentation of cost of sales and general and administrative expenses to align presentation for operating segments.

Net Loss per Share of Common 20

Net Loss per Share of Common Stock (Tables)	6 Months Ended
	Jun. 30, 2017
Earnings Per Share, Basic and Diluted [Abstract]
Computation of Net Loss per Common Share	Three months ended June 30, Six months ended June 30, 2017 2016 2017 2016 Basic numerator: Net loss from continuing operations attributable to shares of common stock $ (5,458) $ (9,809) $ (11,322) $ (12,984) Net loss from discontinued operations attributable to shares of common stock (1,552) (998) (2,113) (1,778) Net loss attributable to shares of common stock $ (7,010) $ (10,807) $ (13,435) $ (14,762) Basic denominator: Basic shares of common stock outstanding 19,310,994 14,993,686 19,178,769 14,576,183 Basic loss per share of common stock from continuing operations $ (0.28) $ (0.65) $ (0.59) $ (0.89) Basic loss per share of common stock from discontinued operations (0.08) (0.07) (0.11) (0.12) Basic net loss per share of common stock $ (0.36) $ (0.72) $ (0.70) $ (1.01) Diluted numerator: Net loss from continuing operations attributable to shares of common stock $ (5,458) $ (9,809) $ (11,322) $ (12,984) Net loss from discontinued operations attributable to shares of common stock (1,552) (998) (2,113) (1,778) Net loss attributable to shares of common stock $ (7,010) $ (10,807) $ (13,435) $ (14,762) Diluted denominator: Diluted shares of common stock outstanding 19,310,994 14,993,686 19,178,769 14,576,183 Diluted loss per share of common stock from continuing operations $ (0.28) $ (0.65) $ (0.59) $ (0.89) Diluted loss per share of common stock from discontinued operations (0.08) (0.07) (0.11) (0.12) Diluted net loss per share of common stock $ (0.36) $ (0.72) $ (0.70) $ (1.01) Net loss per share data presented excludes from the calculation of diluted net loss the following potentially dilutive securities, as they had an anti-dilutive impact: Both vested and unvested options to purchase an equal number of shares of common stock of the Company 5,135,399 1,492,434 5,135,399 1,492,434 Unvested restricted stock units (“RSUs”) to issue an equal number of shares of common stock of the Company 400,942 7,808 400,942 7,808 Warrants to purchase an equal number of shares of common stock of the Company 3,430,877 1,006,679 3,430,877 1,006,679 Preferred stock on an as converted basis 3,439,587 — 3,620,626 — Conversion feature of senior secured notes — — — 159,462 Total number of potentially dilutive instruments, excluded from the calculation of net loss per share 12,406,805 2,506,921 12,587,844 2,666,383

Business Combinations (Tables)

Business Combinations (Tables)	6 Months Ended
	Jun. 30, 2017
Business Combinations [Abstract]
Components of Recognized Identified Assets Acquired and Liabilities Assumed	The excess of the purchase price over the net tangible assets and intangible assets was recorded as goodwill. The table below presents preliminary allocation of the purchase price: Fair Value Assets Current assets (including cash of $26) $ 628 Deferred tax assets 29 Property and equipment 21 Intangible assets 556 Goodwill 2,320 Total assets 3,554 Liabilities Accounts payable and accrued expenses 1,214 Deferred tax liabilities 215 Total liabilities 1,429 Net assets, fair value $ 2,125

Segment Information (Tables)

Segment Information (Tables)	6 Months Ended
	Jun. 30, 2017
Segment Reporting [Abstract]
Schedule of Segment Reporting Information	Three months ended June 30, Six months ended June 30, 2017 2016 2017 2016 Revenue Wellness $ 12,927 $ — $ 23,911 $ — Technology 3,450 2,450 6,941 3,727 Intellectual property — 8,900 100 9,650 Total revenue 16,377 11,350 30,952 13,377 Cost of sales Wellness 10,401 — 19,236 — Technology 2,690 2,180 5,618 3,304 Intellectual property 118 4,243 217 4,963 Total cost of sales 13,209 6,423 25,071 8,267 Segment operating loss Wellness (1,992) — (4,363) — Technology (742) (327) (1,656) (648) Intellectual property (126) (7,577) (131) (8,280) Corporate (2,270) (1,814) (4,463) (3,616) Total segment operating loss (5,130) (9,718) (10,613) (12,544) Corporate non-operating expense, net (228) (91) (306) (440) Loss from continuing operations before income taxes $ (5,358) $ (9,809) $ (10,919) $ (12,984) June 30, 2017 December 31, 2016 Assets Wellness $ 53,137 $ 57,527 Technology 4,602 8,634 Intellectual property 825 940 Corporate 13,818 15,706 Total assets $ 72,382 $ 82,807
Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area	Three months ended June 30, Six months ended June 30, 2017 2016 2017 2016 Revenue United States $ 15,115 $ 11,350 $ 28,574 $ 13,377 All other countries 1,262 — 2,378 — Total revenue 16,377 11,350 30,952 13,377 Cost of sales United States 12,384 6,423 23,569 8,267 All other countries 825 — 1,502 — Total cost of sales 13,209 6,423 25,071 8,267 Segment operating income (loss) United States (5,636) (9,713) (11,309) (12,541) All other countries 506 (5) 696 (3) Total segment operating income (loss) (5,130) (9,718) (10,613) (12,544) Corporate non-operating expense, net (228) (91) (306) (440) Loss from continuing operations before income taxes $ (5,358) $ (9,809) $ (10,919) $ (12,984) June 30, 2017 December 31, 2016 Assets United States $ 70,380 $ 80,053 All other countries 2,002 2,754 Total assets $ 72,382 $ 82,807

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Jun. 30, 2017
Fair Value Disclosures [Abstract]
Assets and Liabilities Measured at Fair Value on Recurring Basis	The following table presents the placement in the fair value hierarchy of derivate warrant liabilities measured at fair value on a recurring basis as of June 30, 2017 and December 31, 2016: Fair value measurement at reporting date using Quoted prices in active markets Significant other Significant for identical observable unobservable Balance assets (Level 1) inputs (Level 2) inputs (Level 3) June 30, 2017: May 2015 Warrants $ 100 $ — $ — $ 100 December 31, 2016: May 2015 Warrants $ 259 $ — $ — $ 259
Changes in Liabilities Measured at Fair Value Using Significant Unobservable Inputs	The following table summarizes the changes in the Company’s derivative warrant liabilities measured at fair value using significant unobservable inputs (Level 3) during the three- and six-month periods ended June 30, 2017: May 2015 Warrants December 31, 2016 $ 259 Decrease in fair value of the derivative warrant liabilities (159) June 30, 2017 $ 100
Fair Value Measurements Based Upon Sensitivity and Nature of Inputs	The fair value measurements are evaluated by management to ensure that changes are consistent with expectations of management based upon the sensitivity and nature of the inputs. June 30, 2017: Description Valuation technique Unobservable inputs Range May 2015 Warrants Black-Scholes-Merton Volatility 42.12 % Risk free interest rate 1.51 % Expected term, in years 2.84 Dividend yield 0.00 % December 31, 2016: Description Valuation technique Unobservable inputs Range May 2015 Warrants Black-Scholes-Merton Volatility 45.15 % Risk-free interest rate 1.57 % Expected term, in years 3.34 Dividend yield 0.00 %
Assets and Liabilities Measured at Fair Value on Nonrecurring Basis	The following table presents the placement in the fair value hierarchy of shares of the contingent consideration assumed by the Company following the acquisition of Excalibur, which is measured at fair value on a recurring basis, and the decrease in shares of FORM Preferred Stock issued to the XpresSpa Sellers, which was measured at fair value on a non-recurring basis as of April 4, 2017 (the “Valuation Date”): Fair value measurement at reporting date using Quoted prices in active markets Significant other Significant for identical observable unobservable Balance assets (Level 1) inputs (Level 2) inputs (Level 3) June 30, 2017: Contingent consideration $ 316 $ — $ — $ 316 FORM Preferred Stock $ 908 $ — $ — $ 908
Preferred Stock, the Monte-carlo Simulation Variables	To estimate the fair value of the decrease in shares of FORM Preferred Stock, the Monte-Carlo simulation was performed using the following variables: Description Valuation technique Variables Range FORM Preferred Stock Monte-Carlo Share price as of the Valuation Date $ 1.95 Volatility 46.0 % Risk free interest rate 2.22 %

Stock-based Compensation (Table

Stock-based Compensation (Tables)	6 Months Ended
	Jun. 30, 2017
Stock Options and Restricted Stock Units Activity	The activity related to stock options and RSUs during the six-month period ended June 30, 2017 consisted of the following: RSUs Options Weighted Weighted Weighted average average average No. of grant date No. of exercise Exercise grant date RSUs fair value options price price range fair value Outstanding as of January 1, 2017 — — 3,679,101 $ 7.60 $ 1.55 – 55.00 $ 5.41 Granted 400,942 $ 2.12 1,545,000 $ 2.12 $ 2.12 – 2.15 $ 0.93 Vested/Exercised — — — — — — Forfeited — — (72,334) $ 24.80 $ 1.55 – 37.20 $ 16.81 Expired — — (16,368) $ 43.66 $ 9.94 – 55.00 $ 22.02 Outstanding as of June 30, 2017 400,942 $ 2.12 5,135,399 $ 5.60 $ 1.55 – 41.00 $ 3.85 Exercisable as of June 30, 2017 — 2,459,982 $ 9.72 $ 1.55 – 41.00
Directors and Employees [Member]
Schedule of Options Granted	The following table illustrates the options granted during the six-month period ended June 30, 2017. Assumptions used in Black- No. of Exercise Fair value at Scholes option pricing Title Grant date options price grant date Vesting terms model Directors, management, and January 2017 1,545,000 $2.12 – $2.15 $0.89 – $0.96 Over 1 year for directors; Over 3 years Volatility: 44.27% – 44.90% employees for management and employees Risk free interest rate: 1.95% – 2.16% Expected term, in years: 5.29 – 5.79 Dividend yield: 0.00%
Management and Employees [Member]
Schedule of Options Granted	The following table illustrates the RSUs granted during the six-month period June 30, 2017. Title Grant date No. of RSUs Fair value at grant date Vesting term Management and employees January 2017 400,942 $ 2.12 Over 1 year period, vesting on 1 year anniversary of grant date

Discontinued Operations and A25

Discontinued Operations and Assets and Liabilities Held For Disposal (Tables)	6 Months Ended
	Jun. 30, 2017
Discontinued Operations and Disposal Groups [Abstract]
Disposal Groups, Including Discontinued Operations [Table Text Block]	The following table represents the components of operating results from discontinued operations, as presented in the condensed consolidated statements of operations and comprehensive loss : Three months ended June 30, Six months ended June 30, 2017 2016 2017 2016 Revenue $ 19 13 53 $ 29 Cost of sales (36) — (68) (2) Depreciation, amortization and impairment (1,130) (21) (1,168) (42) General and administrative (405) (990) (930) (1,763) Loss from discontinued operations before income taxes (1,552) (998) (2,113) (1,778) Income tax expense — — — — Net loss from discontinued operations $ (1,552) $ (998) $ (2,113) $ (1,778) In addition, the following table presents the carrying amounts of the major classes of assets and liabilities held for sale as of June 30, 2017 and December 31, 2016, as presented in the condensed consolidated balance sheets. June 30, 2017 December 31, 2016 Accounts receivable, net $ 39 $ 45 Inventory 208 53 Other current assets 24 92 Property and equipment, net 196 183 Intangible assets, net — 377 Goodwill — 757 Assets held for disposal $ 467 $ 1,507 Accounts payable, accrued expenses and other current liabilities $ 88 $ 196 Deferred revenue 9 10 Liabilities held for disposal $ 97 $ 206

General (Additional Information

General (Additional Information) (Details) - Infomedia [Member]	Jun. 30, 2017
Maximum [Member]
Cost Method Investment Ownership Percentage	11.00%
Minimum [Member]
Cost Method Investment Ownership Percentage	8.25%

Net Loss per Share of Common 27

Net Loss per Share of Common Stock (Computation of basic and diluted net losses per common share) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Earnings Per Share Disclosure [Line Items]
Net loss attributable to shares of common stock	$ (7,010)	$ (10,807)	$ (13,435)	$ (14,762)
Basic shares of common stock outstanding	19,310,994	14,993,686	19,178,769	14,576,183
Diluted shares of common stock outstanding	19,310,994	14,993,686	19,178,769	14,576,183
Net loss per share data presented excludes from the calculation of diluted net loss the following potentially dilutive securities, as they had an anti-dilutive impact:
Total number of potentially dilutive instruments, excluded from the calculation of net loss per share	12,406,805	2,506,921	12,587,844	2,666,383
Basic numerator [Member]
Earnings Per Share Disclosure [Line Items]
Net loss from continuing operations attributable to shares of common stock	$ (5,458)	$ (9,809)	$ (11,322)	$ (12,984)
Net loss from discontinued operations attributable to shares of common stock	(1,552)	(998)	(2,113)	(1,778)
Net loss attributable to shares of common stock	$ (7,010)	$ (10,807)	$ (13,435)	$ (14,762)
Basic denominator [Member]
Earnings Per Share Disclosure [Line Items]
Basic shares of common stock outstanding	19,310,994	14,993,686	19,178,769	14,576,183
Basic loss per share of common stock from continuing operations	$ (0.28)	$ (0.65)	$ (0.59)	$ (0.89)
Basic loss per share of common stock from discontinued operations	(0.08)	(0.07)	(0.11)	(0.12)
Basic net loss per share of common stock	$ (0.36)	$ (0.72)	$ (0.70)	$ (1.01)
Diluted numerator [Member]
Earnings Per Share Disclosure [Line Items]
Net loss from continuing operations attributable to shares of common stock	$ (5,458)	$ (9,809)	$ (11,322)	$ (12,984)
Net loss from discontinued operations attributable to shares of common stock	(1,552)	(998)	(2,113)	(1,778)
Net loss attributable to shares of common stock	$ (7,010)	$ (10,807)	$ (13,435)	$ (14,762)
Diluted denominator [Member]
Earnings Per Share Disclosure [Line Items]
Diluted shares of common stock outstanding	19,310,994	14,993,686	19,178,769	14,576,183
Diluted loss per share of common stock from continuing operations	$ (0.28)	$ (0.65)	$ (0.59)	$ (0.89)
Diluted loss per share of common stock from discontinued operations	(0.08)	(0.07)	(0.11)	(0.12)
Diluted net loss per share of common stock	$ (0.36)	$ (0.72)	$ (0.70)	$ (1.01)
Vested and unvested options to purchase an equal number of shares of common stock of the Company [Member]
Net loss per share data presented excludes from the calculation of diluted net loss the following potentially dilutive securities, as they had an anti-dilutive impact:
Total number of potentially dilutive instruments, excluded from the calculation of net loss per share	5,135,399	1,492,434	5,135,399	1,492,434
Unvested Restricted Stock Units ("RSU") [Member]
Net loss per share data presented excludes from the calculation of diluted net loss the following potentially dilutive securities, as they had an anti-dilutive impact:
Total number of potentially dilutive instruments, excluded from the calculation of net loss per share	400,942	7,808	400,942	7,808
Warrants to purchase an equal number of shares of common stock of the Company [Member]
Net loss per share data presented excludes from the calculation of diluted net loss the following potentially dilutive securities, as they had an anti-dilutive impact:
Total number of potentially dilutive instruments, excluded from the calculation of net loss per share	3,430,877	1,006,679	3,430,877	1,006,679
Conversion feature of Senior Secured Notes [Member]
Net loss per share data presented excludes from the calculation of diluted net loss the following potentially dilutive securities, as they had an anti-dilutive impact:
Total number of potentially dilutive instruments, excluded from the calculation of net loss per share	0	0	0	159,462
Convertible Perferred Stock [Member]
Net loss per share data presented excludes from the calculation of diluted net loss the following potentially dilutive securities, as they had an anti-dilutive impact:
Total number of potentially dilutive instruments, excluded from the calculation of net loss per share	3,439,587	0	3,620,626	0

Business Combinations (Addition

Business Combinations (Additional Information) (Details) - USD ($) $ / shares in Units, $ in Thousands	Feb. 02, 2017	Jun. 30, 2017	Jun. 30, 2017	Jul. 26, 2017	Dec. 31, 2016
Business Combination [Line Items]
Common Stock, Par Or Stated Value Per Share	$ 0.01	$ 0.01	$ 0.01		$ 0.01
Business Combination, Consideration Transferred	$ 2,125
Stock Issued During Period, Shares, Acquisitions	888,573
Business Combination, Consideration Transferred, Liabilities Incurred	$ 316
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable	$ 1,809
Business Combination, Control Obtained Description	to the former stockholders of Excalibur (the “Excalibur Sellers”). In addition, the Excalibur Sellers will, in the three years following the closing of this transaction, also receive $500 for each $2,000 of gross profit generated by a specified list of Excalibur accounts annually, until such cumulative gross profit reaches $6,000, and an additional $500 when such cumulative profit reaches $10,000, such amounts are payable in either cash or the Company’s common stock, at the election of the Company.
Adjustments to Additional Paid in Capital, Increase in Carrying Amount of Redeemable Preferred Stock			$ 908
Subsequent Event [Member]
Business Combination [Line Items]
Shares Issued, Price Per Share				$ 1.10
Subsequent Event [Member] | Over-Allotment Option [Member]
Business Combination [Line Items]
Shares Issued, Price Per Share				$ 1.023
Common Stock [Member]
Business Combination [Line Items]
Adjustments to Additional Paid in Capital, Increase in Carrying Amount of Redeemable Preferred Stock			$ 0
Common Stock [Member] | XpresSpa Holdings LLC [Member]
Business Combination [Line Items]
Conversion of Stock, Shares Issued			362,077
FORM Preferred Stock [Member] | XpresSpa Holdings LLC [Member]
Business Combination [Line Items]
Common Stock, Par Or Stated Value Per Share		$ 0.01	$ 0.01
Preferred Stock, Liquidation Preference, Value		$ 20,638	$ 20,638		$ 23,588
Preferred Stock, Shares Outstanding		429,948	429,948		491,427
Conversion of Stock, Shares Converted		45,260
Preferred Stock Shares Reduction			16,219

Business Combinations (Purchase

Business Combinations (Purchase Price The Net Tangible assets And Intangible Assets Allocation) (Details) - USD ($) $ in Thousands	Jun. 30, 2017	Dec. 31, 2016
Assets
Goodwill	$ 25,821	$ 24,409
Excalibur [Member]
Assets
Current assets (including cash of $26)	628
Deferred tax assets	29
Property and equipment	21
Intangible assets	556
Goodwill	2,320
Total assets	3,554
Liabilities
Accounts payable and accrued expenses	1,214
Deferred tax liabilities	215
Total liabilities	1,429
Net assets, fair value	$ 2,125

Segment Information (Details)

Segment Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016	Dec. 31, 2016
Revenue:
Total revenue	$ 16,377	$ 11,350	$ 30,952	$ 13,377
Cost of sales
Total cost of sales	13,209	6,423	25,071	8,267
Segment operating loss:
Total segment operating loss	(5,130)	(9,718)	(10,613)	(12,544)
Corporate non-operating expense, net	(228)	(91)	(306)	(440)
Loss from continuing operations before income taxes	(5,358)	(9,809)	(10,919)	(12,984)
Assets
Total assets	72,382		72,382		$ 82,807
Corporate [Member]
Segment operating loss:
Total segment operating loss	(2,270)	(1,814)	(4,463)	(3,616)
Assets
Total assets	13,818		13,818		15,706
Intellectual Property [Member]
Revenue:
Total revenue	0	8,900	100	9,650
Cost of sales
Total cost of sales	118	4,243	217	4,963
Segment operating loss:
Total segment operating loss	(126)	(7,577)	(131)	(8,280)
Assets
Total assets	825		825		940
Wellness Service [Member]
Revenue:
Total revenue	12,927	0	23,911	0
Cost of sales
Total cost of sales	10,401	0	19,236	0
Segment operating loss:
Total segment operating loss	(1,992)	0	(4,363)	0
Assets
Total assets	53,137		53,137		57,527
Technology Service [Member]
Revenue:
Total revenue	3,450	2,450	6,941	3,727
Cost of sales
Total cost of sales	2,690	2,180	5,618	3,304
Segment operating loss:
Total segment operating loss	(742)	$ (327)	(1,656)	$ (648)
Assets
Total assets	$ 4,602		$ 4,602		$ 8,634

Segment Information (Geographic

Segment Information (Geographical Revenue, Segment Operating Loss and Total Asset Information) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016	Dec. 31, 2016
Revenue
Total revenue	$ 16,377	$ 11,350	$ 30,952	$ 13,377
Cost of sales
Total cost of sales	13,209	6,423	25,071	8,267
Segment operating income (loss)
Total segment operating income (loss)	(5,130)	(9,718)	(10,613)	(12,544)
Corporate non-operating expense, net	(228)	(91)	(306)	(440)
Loss from continuing operations before income taxes	(5,358)	(9,809)	(10,919)	(12,984)
Assets
Assets	72,382		72,382		$ 82,807
United States
Revenue
Total revenue	15,115	11,350	28,574	13,377
Cost of sales
Total cost of sales	12,384	6,423	23,569	8,267
Segment operating income (loss)
Total segment operating income (loss)	(5,636)	(9,713)	(11,309)	(12,541)
Assets
Assets	70,380		70,380		80,053
All other countries
Revenue
Total revenue	1,262	0	2,378	0
Cost of sales
Total cost of sales	825	0	1,502	0
Segment operating income (loss)
Total segment operating income (loss)	506	$ (5)	696	$ (3)
Assets
Assets	$ 2,002		$ 2,002		$ 2,754

Fair Value Measurements (Assets

Fair Value Measurements (Assets and Liabilities Measured at Fair Value on Recurring Basis) (Details) - Warrant [Member] - USD ($) $ in Thousands	Jun. 30, 2017	Dec. 31, 2016
Liabilities
Derivative liabilities	$ 100	$ 259
Fair Value, Inputs, Level 1 [Member]
Liabilities
Derivative liabilities	0	0
Fair Value, Inputs, Level 2 [Member]
Liabilities
Derivative liabilities	0	0
Fair Value Inputs Level 3 [Member]
Liabilities
Derivative liabilities	$ 100	$ 259

Fair Value Measurements (Change

Fair Value Measurements (Changes In Company's Liabilities Measured At Fair Value Using Significant Unobservable Inputs) (Details) - May Twenty Fifteen Warrants [Member] $ in Thousands	6 Months Ended
	Jun. 30, 2017USD ($)
Derivative Liability, December 31, 2016	$ 259
Decrease in fair value of the derivative warrant liabilities	(159)
Derivative Liability, June 30, 2017	$ 100

Fair Value Measurements (Based

Fair Value Measurements (Based Upon Sensitivity and Nature of Inputs) (Details) - May 2015 Warrants [Member]	6 Months Ended	12 Months Ended
	Jun. 30, 2017	Dec. 31, 2016
Fair Value Inputs, Liabilities, Quantitative Information [Line Items]
Volatility	42.12%	45.15%
Risk free interest rate	1.51%	1.57%
Expected term, in years	2 years 10 months 2 days	3 years 4 months 2 days
Dividend yield	0.00%	0.00%

Fair Value Measurement (Intangi

Fair Value Measurement (Intangible Assets Measured At Fair Value On A Non-Recurring Basis) (Details) - Fair Value, Measurements, Recurring [Member] $ in Thousands	Jun. 30, 2017USD ($)
FORM Preferred Stock [Member]
Fair Value, Assets Measured on Recurring and Nonrecurring Basis, Alternative [Abstract]
Liabilities, Fair Value Disclosure, Nonrecurring	$ 908
Contingent consideration [Member]
Fair Value, Assets Measured on Recurring and Nonrecurring Basis, Alternative [Abstract]
Liabilities, Fair Value Disclosure, Recurring	316
Fair Value, Inputs, Level 2 [Member] | FORM Preferred Stock [Member]
Fair Value, Assets Measured on Recurring and Nonrecurring Basis, Alternative [Abstract]
Liabilities, Fair Value Disclosure, Nonrecurring	0
Fair Value, Inputs, Level 2 [Member] | Contingent consideration [Member]
Fair Value, Assets Measured on Recurring and Nonrecurring Basis, Alternative [Abstract]
Liabilities, Fair Value Disclosure, Recurring	0
Fair Value Inputs Level 3 [Member] | FORM Preferred Stock [Member]
Fair Value, Assets Measured on Recurring and Nonrecurring Basis, Alternative [Abstract]
Liabilities, Fair Value Disclosure, Nonrecurring	908
Fair Value Inputs Level 3 [Member] | Contingent consideration [Member]
Fair Value, Assets Measured on Recurring and Nonrecurring Basis, Alternative [Abstract]
Liabilities, Fair Value Disclosure, Recurring	316
Fair Value, Inputs, Level 1 [Member] | FORM Preferred Stock [Member]
Fair Value, Assets Measured on Recurring and Nonrecurring Basis, Alternative [Abstract]
Liabilities, Fair Value Disclosure, Nonrecurring	0
Fair Value, Inputs, Level 1 [Member] | Contingent consideration [Member]
Fair Value, Assets Measured on Recurring and Nonrecurring Basis, Alternative [Abstract]
Liabilities, Fair Value Disclosure, Recurring	$ 0

Fair Value Measurements ( FORM

Fair Value Measurements ( FORM Preferred Stock, the Monte-Carlo simulation variables) (Details) - Fair Value Inputs Level 3 [Member]	6 Months Ended
	Jun. 30, 2017$ / shares
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair Value Measurements, Valuation Processes, Description	FORM Preferred Stock
Fair Value Measurements, Valuation Techniques	Monte-Carlo
Share price as of the Valuation Date	$ 1.95
Volatility	46.00%
Risk free interest rate	2.22%

Stock-based Compensation (Addit

Stock-based Compensation (Additional Information) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Stockholders Equity [Line Items]
Share-Based Compensation	$ 732	$ 499	$ 1,473	$ 962
Two Thousand Twelve Stock Option Plan [Member]
Stockholders Equity [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	1,258,603		1,258,603

Stock-based Compensation (Sched

Stock-based Compensation (Schedule Of Common Stock Options Granted) (Details) - $ / shares	6 Months Ended
	Jun. 30, 2017	Dec. 31, 2016
Stockholders Equity [Line Items]
Exercise price	$ 5.60	$ 7.6
Fair value at grant date	0.93
Maximum [Member]
Stockholders Equity [Line Items]
Exercise price	41	55
Minimum [Member]
Stockholders Equity [Line Items]
Exercise price	$ 1.55	$ 1.55
Management Directors and Employees [Member] | Employee Stock Option [Member]
Stockholders Equity [Line Items]
Grant date	January 2,017
No. of RSUs Options	1,545,000
Vesting terms	Over 1 year for directors; Over 3 years for management and employees
Volatility Rate, Minimum	44.27%
Volatility Rate, Maximum	44.90%
Risk free interest rate, Minimum	1.95%
Risk free interest rate, Maximum	2.16%
Dividend yield	0.00%
Management Directors and Employees [Member] | Maximum [Member] | Employee Stock Option [Member]
Stockholders Equity [Line Items]
Exercise price	$ 2.15
Fair value at grant date	$ 0.96
Expected term, in years	5 years 9 months 14 days
Management Directors and Employees [Member] | Minimum [Member] | Employee Stock Option [Member]
Stockholders Equity [Line Items]
Exercise price	$ 2.12
Fair value at grant date	$ 0.89
Expected term, in years	5 years 3 months 14 days
Management and Employees [Member] | Restricted Stock Units (RSUs) [Member]
Stockholders Equity [Line Items]
Grant date	January 2,017
No. of RSUs Options	400,942
Fair value at grant date	$ 2.12
Vesting terms	Over 1 year period, vesting on 1 year anniversary of grant date

Stock-based Compensation (Stock

Stock-based Compensation (Stock options and RSU activity) (Details)	6 Months Ended
	Jun. 30, 2017$ / sharesshares
Stockholders Equity [Line Items]
No. of options, Outstanding | shares	3,679,101
No. of options, Granted | shares	1,545,000
No. of options, Vested/Exercised | shares	0
No. of options, Forfeited | shares	(72,334)
No. of options, Expired | shares	(16,368)
No. of options, Outstanding | shares	5,135,399
No. of options, Exercisable | shares	2,459,982
Exercise price range, Outstanding	$ 7.6
Exercise price range, Granted	2.12
Exercise price range, Vested/Exercised	0
Exercise price range, Forfeited	24.80
Exercise price range, Expired	43.66
Exercise price range, Outstanding	5.60
Exercise price range, Exercisable	9.72
Weighted average grant date fair value, Outstanding	5.41
Weighted average grant date fair value, Granted	0.93
Weighted average grant date fair value, Vested/Exercised	0
Weighted average grant date fair value, Forfeited	16.81
Weighted average grant date fair value, Expired	22.02
Weighted average grant date fair value, Outstanding	$ 3.85
Restricted Stock [Member]
Stockholders Equity [Line Items]
No. of RSUS, Outstanding | shares	0
No. of RSUs, Granted | shares	400,942
No. of RSUs, Vested/Exercised | shares	0
No. of RSUs, Forfeited | shares	0
No. of RSUs, Expired | shares	0
No. of RSUS, Outstanding | shares	400,942
No. of RSUs, Exercisable | shares	0
Weighted average grant date fair value, Outstanding	$ 0
Weighted average grant date fair value, Granted	2.12
Weighted average grant date fair value, Vested/Exercised	0
Weighted average grant date fair value, Forfeited	0
Weighted average grant date fair value, Expired	0
Weighted average grant date fair value, Outstanding	2.12
Weighted average grant date fair value, Exercisable	0
Minimum [Member]
Stockholders Equity [Line Items]
Exercise price range, Outstanding	1.55
Exercise price range, Granted	2.12
Exercise price range, Forfeited	1.55
Exercise price range, Expired	9.94
Exercise price range, Outstanding	1.55
Exercise price range, Exercisable	1.55
Maximum [Member]
Stockholders Equity [Line Items]
Exercise price range, Outstanding	55
Exercise price range, Granted	2.15
Exercise price range, Forfeited	37.20
Exercise price range, Expired	55
Exercise price range, Outstanding	41
Exercise price range, Exercisable	$ 41

Income Taxes (Additional Inform

Income Taxes (Additional Information) (Details) $ in Thousands	6 Months Ended
	Jun. 30, 2017USD ($)
Income Taxes [Line Items]
Effective Income Tax Rate Reconciliation, Percent	(3.96%)
Business Acquisition, Goodwill, Expected Tax Deductible Amount	$ 227
Effective Income Tax Rate Discontinued Operations	0.58%

Related Parties Transactions (A

Related Parties Transactions (Additional Information) (Details) - USD ($) $ in Thousands	1 Months Ended	6 Months Ended
	Mar. 31, 2017	Jun. 30, 2017	Dec. 31, 2016
Bruce T. Bernstein [Member]
Payments for Legal Settlements	$ 212
XpresSpa Engagement [Member]
Debt Instrument, Face Amount		$ 6,500	$ 6,500
Payments For Interest Expenses		430
Interest Expense, Debt		$ 365
Debt Instrument, Maturity Date Range, Start		May 1, 2018
Debt Instrument, Maturity Date Range, End		May 1, 2019

Discontinued Operations and A42

Discontinued Operations and Assets and Liabilities Held For Disposal (Additional Information) (Details) $ in Thousands	6 Months Ended
	Jun. 30, 2017USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Equity Method Investment, Other than Temporary Impairment	$ 1,092

Discontinued Operations and A43

Discontinued Operations and Assets and Liabilities Held For Disposal (Schedule Of Discontinued Operations, As Presented In Consolidated Statements Of Operations) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Revenue	$ 19	$ 13	$ 53	$ 29
Cost of sales	(36)	0	(68)	(2)
Depreciation, amortization and impairment	(1,130)	(21)	(1,168)	(42)
General and administrative	(405)	(990)	(930)	(1,763)
Loss from discontinued operations before income taxes	(1,552)	(998)	(2,113)	(1,778)
Income tax expense	0	0	0	0
Net loss from discontinued operations	$ (1,552)	$ (998)	$ (2,113)	$ (1,778)

Discontinued Operations and A44

Discontinued Operations and Assets and Liabilities Held For Disposal (Carrying Amounts Of the Major Classes Of Assets and Liabilities) (Details) - USD ($) $ in Thousands	Jun. 30, 2017	Dec. 31, 2016
Accounts receivable, net	$ 39	$ 45
Inventory	208	53
Other current assets	24	92
Property and equipment, net	196	183
Intangible assets, net	0	377
Goodwill	0	757
Assets held for disposal	467	1,507
Accounts payable, accrued expenses and other current liabilities	88	196
Deferred revenue	9	10
Liabilities held for disposal	$ 97	$ 206

Commitments and Contingencies (

Commitments and Contingencies (Additional Information) (Details)	Jun. 30, 2017USD ($)
Accrued Liabilities [Member]
Loss Contingencies [Line Items]
Estimated Litigation Liability, Current	$ 650

Subsequent Events (Additional I

Subsequent Events (Additional Information) (Details) - USD ($)	1 Months Ended
	Jul. 26, 2017	Jun. 30, 2017	Dec. 31, 2016
Subsequent Event [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number		5,135,399	3,679,101
Subsequent Event [Member]
Subsequent Event [Line Items]
Stock Issued During Period, Shares, New Issues	6,900,000
Proceeds from Issuance of Common Stock	$ 6,700
Shares Issued, Price Per Share	$ 1.10
Subsequent Event [Member] | Over-Allotment Option [Member]
Subsequent Event [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	900,000
Shares Issued, Price Per Share	$ 1.023